Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05252221 · ClinicalTrials.gov registry record · NA
Alcohol Telemedicine Consultation in Primary Care (ATC)
A NA study of Alcohol Use Disorder (AUD) and Alcohol Problem, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 41,843
- Enrollment target
- 2
- Study locations
NCT05252221: Completed NA study of Alcohol Use Disorder (AUD) and Alcohol Problem, sponsored by Kaiser Permanente.
NCT05252221 is a NA study of Alcohol Use Disorder (AUD) and Alcohol Problem that has completed, run by Kaiser Permanente. The registered enrollment target is 41,843 participants, above the 429-participant average among 30 other Alcohol Use Disorder (AUD) trials with a reported enrollment target (9654% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05252221, a NA study of Alcohol Use Disorder (AUD) and Alcohol Problem, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 41,843 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pragmatic, cluster-randomized trial in adult primary care clinics in a healthcare system with a diverse membership will examine the effectiveness of an innovative, multi-faceted intervention, the Addiction Telemedicine Consultant (ATC) service using clinical pharmacists to facilitate alcohol use problems and alcohol use disorder (AUD) pharmacotherapy and specialty addiction treatment entry.
Primary Outcome
AUD Medication Prescription Rate
Conditions Studied
Interventions
- OTHER ATC Intervention
Study Locations (2)
California
- Kaiser Permanente - Oakland
- Kaiser Permanente - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41,843 participants |
| Start Date | 2021-09-14 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
What the finished NCT05252221 record still lists
NCT05252221 is an interventional study that assigns participants to a tested intervention. Its 41,843 participants enrollment target places it among the larger protocols in the corpus, above the 429-participant average among 30 other Alcohol Use Disorder (AUD) trials with a reported enrollment target (9654% higher).
The record links to 3 conditions, with Alcohol Use Disorder (AUD) appearing as the primary indexed condition, and to 1 intervention - of which ATC Intervention is the first listed.
NCT05252221 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05252221 about?
NCT05252221 is a clinical study titled "Alcohol Telemedicine Consultation in Primary Care (ATC)". This pragmatic, cluster-randomized trial in adult primary care clinics in a healthcare system with a diverse membership will examine the effectiveness of an innovative, multi-faceted intervention, the Addiction Telemedicine Consultant (ATC) service using clinical pharmacists to facilitate alcohol us...
What is the current status of trial NCT05252221?
This trial is currently completed. It is a NA study. The enrollment target is 41,843 participants. The study started on 2021-09-14. Estimated completion is 2023-08-31.
What conditions does trial NCT05252221 study?
This clinical trial studies the following conditions: Alcohol Use Disorder (AUD), Alcohol Problem, Pharmacist-Patient Relations.
What interventions are being tested in trial NCT05252221?
The interventions under investigation include: ATC Intervention (OTHER).
Who is sponsoring clinical trial NCT05252221?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05252221 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder (AUD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05252221's enrollment target sits among peer trials
41,843 1st of 30 higher than 30 of 30 other Alcohol Use Disorder (AUD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder (AUD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
The Oklahoma Parent-Child Assistance Program
RECRUITING · NA
-
MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive Salience
RECRUITING · NA
-
Combining a Smartphone App With Medications to Manage Heavy Drinking
RECRUITING · NA
-
iTBS for Alcohol Use Disorder
RECRUITING · NA
-
Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alcohol Use Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI